China's rare disease sector is entering a strategic window for biomedical innovation, as the country's expanding diagnosis network and relatively large unmet medical needs create new momentum for drug development, clinical translation and payment support mechanisms, a top rare

China's rare disease sector is entering a strategic window for biomedical innovation, as the country's expanding diagnosis network and relatively large unmet medical needs create new momentum for drug development, clinical translation and payment support mechanisms, a top rare

Go to News Site